Clinical Trials in Baltimore

Showing 9421-9440 of 23,476 trials

Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)

NCT04897074

The purpose of this study is to evaluate the effects of videogame-like digital therapy on attentional functioning and symptoms in adolescents ages 13-17 diagnosed with ADHD

Attention Deficit Hyperactivity Disorder

Akili Interactive Labs, Inc.165 participantsStarted Jun 2021

Scottsdale, Arizona, United States • San Diego, California, United States • Maitland, Florida, United States +11 more locations

TERMINATEDPhase 1< 1 mile

A Study of FT-7051 in Men With MCRPC

NCT04575766

This is a Phase 1, open-label study that will evaluate the safety and tolerability of FT-7051 and determine the recommended Phase 2 dose (RP2D) as well as pharmacokinetics (PK), preliminary anti-tumor activity, and pharmacodynamics (PD) of FT-7051 in men with metastatic castration-resistant prostate cancer who have progressed despite prior therapy and had been treated with at least one potent anti-androgen therapy. The starting dose, 25 mg once daily (QD), of FT-7051 administered discontinuously (21 days on/7 days off) in 28-day cycles.

Metastatic Castration-resistant Prostate Cancer

Novo Nordisk A/S25 participantsStarted Dec 2020

Scottsdale, Arizona, United States • Aurora, Colorado, United States • Chicago, Illinois, United States +5 more locations

Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)

A Study of FT-7051 in Men With MCRPC

Find Trials by Condition in Baltimore

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma

A Study to Assess Safety, Tolerability, PK and PD of AZD2373 in Healthy Male Participants of Sub-Saharan West African Ancestry

SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis

Study of OT-101 in Treating Myopia

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion

Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

RObotic Versus LAparoscopic Resection for Rectal Cancer

ADVM-022 Intravitreal Gene Therapy for Wet AMD

Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort

A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain

Dose Optimization Study of Idelalisib in Follicular Lymphoma

Zalutumumab in Non-curable Patients With SCCHN